Regulating Speech About a Drug’s Off-Label Uses
Scholar argues that FDA should adopt an evidenced-based approach to regulating drug manufacturers’ speech.
Marketing Formerly Dangerous Drugs
Two scholars find that the removal of FDA health warnings prompts an increase in drug marketing.